Cross-reacting antibodies enhance dengue virus infection in humans - Test2 - elhamkhani - TriplyDB

Cross-reacting antibodies enhance dengue virus infection in humans

Cross-reacting antibodies enhance dengue virus infection in humans

http://www.wikidata.org/entity/Q28281588

about

Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection Controlling dengue with vaccines in Thailand Mechanism and significance of cell type-dependent neutralization of flaviviruses NS1 antigen detecting assays for diagnosing acute dengue infection in people living in or returning from endemic countries The changing epidemiology of dengue in China, 1990-2014: a descriptive analysis of 25 years of nationwide surveillance data Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public health Inhibitory antibodies targeting emerging viruses: advancements and mechanisms Zika-induced antibody response enhances dengue serotype 2 replication in vitro Molecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease Control Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies Immunogenic cross-talk between dengue and Zika viruses The Cellular Bases of Antibody Responses during Dengue Virus Infection Dengue Fever: Causes, Complications, and Vaccine Strategies Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope Antibody Binding Modulates Conformational Exchange in Domain III of Dengue Virus E Protein Recent advances in understanding dengue Regulation of the Host Antiviral State by Intercellular Communications Degrees of maturity: the complex structure and biology of flaviviruses Flavivirus cell entry and membrane fusion Role of microparticles in dengue virus infection and its impact on medical intervention strategies Flavivirus entry receptors: an update The Complexity of a Dengue Vaccine: A Review of the Human Antibody Response Dengue viruses - an overview A model of DENV-3 infection that recapitulates severe disease and highlights the importance of IFN-γ in host resistance to infection Synergistic interactions between the NS3(hel) and E proteins contribute to the virulence of dengue virus type 1 IFN-γ production depends on IL-12 and IL-18 combined action and mediates host resistance to dengue virus infection in a nitric oxide-dependent manner How antibodies alter the cell entry pathway of dengue virus particles in macrophages Systematic Bioinformatic Approach for Prediction of Linear B-Cell Epitopes on Dengue E and prM Protein Circulating serotypes of dengue virus and their incursion into non-endemic areas of Pakistan; a serious threat Autophagy-associated dengue vesicles promote viral transmission avoiding antibody neutralization Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity Structural Analysis of a Dengue Cross-Reactive Antibody Complexed with Envelope Domain III Reveals the Molecular Basis of Cross-Reactivity Obstruction of Dengue Virus Maturation by Fab Fragments of the 2H2 Antibody Genome-wide analyses reveal a highly conserved Dengue virus envelope peptide which is critical for virus viability and antigenic in humans Identification of a New Broadly Cross-reactive Epitope within Domain III of the Duck Tembusu Virus E Protein Epidemiological Characteristics and Risk Factors of Dengue Infection in Korean Travelers Dengue: an update on treatment options Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to DENV4 Infection and Vaccination Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection The complexity of antibody-dependent enhancement of dengue virus infection

P2860

Q21245045-B8189E60-C59B-4AC5-9499-A135A486AE15 Q21562250-69C421B0-115A-476E-9D17-DEF8E6DDAB70 Q23032973-45C40959-BBBA-4A11-921E-B31CF5B6A4ED Q24194181-BFBD9A8A-146F-4485-92B8-A9DBBA33C526 Q24288879-3BAE4D5F-24CA-4420-B79F-E81FB1604937 Q24289308-078C4D2A-2CC6-4298-836B-011CB0893D10 Q24289645-8C95B072-BB72-46F7-9F56-2DFD76FC16D0 Q26262372-2043BE45-7F62-4606-BF1F-A900E3621E4E Q26314452-EDE2B67F-D974-4745-AF8A-2E67A43AD8B4 Q26314715-FBA24526-D146-44A3-87D7-E8F72E3042FE Q26437328-F2CF6498-0067-4977-BFF9-15628274AC0E Q26700056-ED9411C7-1719-46B2-91AA-406DBDE8776A Q26700082-9E196638-961A-43E1-80AF-8314CB41BA31 Q26700120-BC730BA5-1C8B-409B-BB20-4B1EF62EB56C Q26700124-8E6CB835-DE37-4F31-9034-A66FD01BF832 Q26766156-D8EE2106-04BD-4263-B50E-00BE4D39E918 Q26795744-44EBDFEF-204C-4B8D-8C4A-2201754B8028 Q26824712-C80E6567-DB5F-4345-B652-B84DEFF12137 Q26852458-13C5FD4E-8D13-402A-AE9D-F53B141C3860 Q26860307-650A5035-604F-456B-83D1-662FD3878C7E Q26866329-4CF2C609-0513-4ED6-81B3-FD24639171FE Q26995782-36791910-4D4A-449C-B998-86B49173DB4E Q27026302-AFE53E41-0C3E-404B-8F52-FD91B94F863E Q27305445-FB3B67A3-A790-4618-919E-72D7C47D26C5 Q27305534-C77F3681-8AEB-47F9-A377-4B4739FD6D11 Q27305770-457CB5BD-AACB-4CDC-8DF3-B0037AEECCCD Q27334575-5F6F6660-4EBB-4193-8D0A-08D033A49787 Q27468788-64E3C00F-F34D-410C-AD17-7D0399082B38 Q27468814-376AE4D5-AA02-42B6-9CAC-118FBEEDE473 Q27468834-EDA69C3C-B130-4A19-A266-29572410FC15 Q27654848-022140CC-ADC6-4FF7-A06D-B0E0EF135BFD Q27678419-649B0963-D11C-4C34-B3DA-245897314067 Q27678509-27E3B5E2-9504-40B5-9F48-EFE35C0B602C Q27682470-667FD10B-B7F4-43E6-9FD3-F6880812C44A Q27927982-177D2061-7BED-4C06-9812-6F1A8A9644CF Q28080305-848F164A-4129-42AB-B968-14EFEE02CB80 Q28085044-1ACA89C2-740E-4CAA-9A1F-F8269A2FFAA5 Q28114614-56605EF7-7D70-4B01-9C64-49DF7A292F7A Q28119679-091D0743-DC07-41E3-AB54-73C354B04F87 Q28250383-758BAC80-B993-49F9-8C18-B3C52252D993

P2860

Cross-reacting antibodies enhance dengue virus infection in humans

http://www.wikidata.org/entity/Q28281588

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Cross-reacting antibodies enhance dengue virus infection in humans

@ast

Cross-reacting antibodies enhance dengue virus infection in humans

@en

Cross-reacting antibodies enhance dengue virus infection in humans

@nl

type

label

Cross-reacting antibodies enhance dengue virus infection in humans

@ast

Cross-reacting antibodies enhance dengue virus infection in humans

@en

Cross-reacting antibodies enhance dengue virus infection in humans

@nl

prefLabel

Cross-reacting antibodies enhance dengue virus infection in humans

@ast

Cross-reacting antibodies enhance dengue virus infection in humans

@en

Cross-reacting antibodies enhance dengue virus infection in humans

@nl

P1433

Q28281588-13AD818A-4C6C-4D92-835E-44D4F8583772

P1476

Q28281588-A993AD57-BD02-4F25-9143-895BE8BD9DF4

P2093

Q28281588-12EA9920-E44B-4B77-8E3B-4219B8E7E7AA

Q28281588-181B6017-EA01-4ABC-BF27-C232A97BE47F

Q28281588-5663494A-5F60-406C-AAC8-22B86F4626E6

Q28281588-5DD34EDC-B28B-4176-88CB-6A5FE148496F

Q28281588-61981151-ED32-4466-BC99-BCE3768FAC34

Q28281588-72772576-F3DC-4E84-A61C-96FDDB88CD89

Q28281588-736DEBE5-1381-42C5-A1CA-FA54FDC4C953

Q28281588-7379E0C3-F742-49BA-A9EA-80866882D6FE

Q28281588-8126900C-CBFA-4E44-942B-6ED21641F60A

Q28281588-EB0B6AF4-E48C-4E4E-BCE2-37BD38A267DC

P2860

Q28281588-07F7719F-720E-40E1-9B5A-DB4786551E15

Q28281588-2079CD55-8683-4232-88BB-9B7F69C78015

Q28281588-25310F27-444B-4441-A151-FC199A0E5978

Q28281588-37174452-D1B2-4ACD-AD51-7482A973C23D

Q28281588-397B3B86-2FEE-4122-AF39-1BCB8191EDAE

Q28281588-40045212-3D77-475E-A0F8-E43B6AD2CFA1

Q28281588-4D0837B7-0635-4D45-8EF9-7DA673C44FD1

Q28281588-5B6F4284-3453-4263-A26B-51616D192985

Q28281588-75E13C06-EF18-4534-8D1D-73F8098AEFAE

Q28281588-814A28E7-AC1B-4CCC-A883-927E57AC191A

P304

Q28281588-2EEFE929-1B01-4658-B102-E5BA0D7611CA

P31

Q28281588-5B28A8C5-7EE7-4E0C-A8BF-4C4BA1B0D595

P3181

Q28281588-F6EE8779-9215-4D40-AB87-272CBF0B2472

P356

Q28281588-8F6047DC-E7CE-449F-8A69-D540B26EF260

P407

Q28281588-CD174CD9-42D5-4365-9957-11AD2F2C781B

P433

Q28281588-FC2BC1DF-4A4D-40E8-A40D-8DB27C5B3C5A

P478

Q28281588-55D63E3A-D2D6-4373-AC60-A0B5AF8FD856

P50

Q28281588-3E385487-869E-4F05-AA72-8FE5E73A22F9

Q28281588-75FDCCAF-8FF9-4F35-A3D6-893C19726E70

Q28281588-EE687E70-31D5-417B-85BE-E3316BC6B15C

P5008

Q28281588-DE66C0D2-4D10-4C12-849B-43BE9F4B08DE

P577

Q28281588-D076D9D1-87FA-46B2-ACB6-E532B4864C5C

P5875

Q28281588-43AC370D-FC86-463B-AA7D-F1CC75EE01AB

P698

Q28281588-9B7D6119-B41E-445E-BED6-AB7486F66E41

P921

Q28281588-3CBA1046-F07E-4E40-ABAC-573BD8FABFDB

Q28281588-406C7CD6-15CD-49D0-9FB5-2165B9FB128B

P932

Q28281588-C4B07A22-3D0D-4A44-9B88-8F35F4A27AF8

P3181

P356

SCIENCE.1185181

P1433

P1476

Cross-reacting antibodies enhance dengue virus infection in humans

@en

P2093

Amonrat Jumnainsong

http://www.w3.org/2001/XMLSchema#string

Carolyn Edwards

http://www.w3.org/2001/XMLSchema#string

Chunya Puttikhunt

http://www.w3.org/2001/XMLSchema#string

Kriangkrai Chawansuntati

http://www.w3.org/2001/XMLSchema#string

Naruthai Onsirisakul

http://www.w3.org/2001/XMLSchema#string

Patricia Fitton

http://www.w3.org/2001/XMLSchema#string

Prida Malasit

http://www.w3.org/2001/XMLSchema#string

Sirijitt Vasanawathana

http://www.w3.org/2001/XMLSchema#string

Sunpetchuda Supasa

http://www.w3.org/2001/XMLSchema#string

Thaneeya Duangchinda

http://www.w3.org/2001/XMLSchema#string

P2860

Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody

Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II

Differential Modulation of prM Cleavage, Extracellular Particle Distribution, and Virus Infectivity by Conserved Residues at Nonfurin Consensus Positions of the Dengue Virus pr-M Junction

The structural immunology of antibody protection against West Nile virus

Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody

Structure of the dengue virus envelope protein after membrane fusion

The flavivirus precursor membrane-envelope protein complex: structure and maturation

Structure of the immature dengue virus at low pH primes proteolytic maturation

Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak

Prospects for a dengue virus vaccine

P304

745-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

199650

http://www.w3.org/2001/XMLSchema#string

P356

10.1126/SCIENCE.1185181

http://www.w3.org/2001/XMLSchema#string

P407

P433

5979

http://www.w3.org/2001/XMLSchema#string

P478

328

http://www.w3.org/2001/XMLSchema#string

P50

Gavin R Screaton

Juthathip Mongkolsapaya

Wanwisa Dejnirattisai

P5008

P577

2010-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44578607

http://www.w3.org/2001/XMLSchema#string

P698

20448183

http://www.w3.org/2001/XMLSchema#string

P921

P932

3837288

http://www.w3.org/2001/XMLSchema#string